John Canepa
2020
In 2020, John Canepa earned a total compensation of $1.3M as Chief Financial Officer at Candel Therapeutics.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $1,230,085 |
| Salary | $14,231 |
| Total | $1,319,316 |
Canepa received $1.2M in option awards, accounting for 93% of the total pay in 2020.
Canepa also received $75K in bonus and $14.2K in salary.
Rankings
In 2020, John Canepa's compensation ranked 7,405th out of 13,090 executives tracked by ExecPay. In other words, Canepa earned more than 43.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,405 out of 13,090 | 43rd |
Division Manufacturing | 3,103 out of 5,621 | 45th |
Major group Chemicals And Allied Products | 1,251 out of 2,254 | 45th |
Industry group Drugs | 1,080 out of 1,954 | 45th |
Industry Biological Products, Except Diagnostic Substances | 255 out of 411 | 38th |
Source: SEC filing on September 2, 2022.
Canepa's colleagues
We found two more compensation records of executives who worked with John Canepa at Candel Therapeutics in 2020.